Jane Street
MBOT icon

Jane Street’s Microbot Medical MBOT Stock Holding History

Jane Street’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,600
Closed -$25.5K – 12499
2026
Q1 		$25.5K Buy
+10,600
New +$23.7K ﹤0.01% 11147

Other funds holding MBOT

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Jane Street's MBOT Position: Q2 2026 in Review

Jane Street reduced its Microbot Medical (MBOT) stake by 25% in Q2 2026, selling an estimated $72.2K and leaving 106,134 shares worth $207K. The position accounts for ﹤0.01% of the portfolio, ranked #10063.

Jane Street first reported a position in MBOT in Q1 2014 and has held it in 8 quarters since. The position peaked at $591K in Q3 2025. 71 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.

  • Jane Street held 106,134 shares of Microbot Medical worth $207K as of Q2 2026.
  • Jane Street sold 35,407 Microbot Medical shares in Q2 2026, an estimated $72.2K.
  • Microbot Medical made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10063 holding.
  • Jane Street first reported a position in Microbot Medical in Q1 2014 and has held it in 8 quarters since.
  • Jane Street's Microbot Medical position peaked at $591K in Q3 2025.
  • 71 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.